Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ALKEM | NSE
-69.50
-1.22%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
22/04/2026
5,627.00
5,685.00
5,735.00
5,539.00
Alkem Laboratories Limited a pharmaceutical company engages in the development manufacture and sale of pharmaceutical and nutraceutical products in India and internationally. The company offers branded generics generic drugs active pharmaceutical ingredients biosimilars and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective dermatology cardiac respiratory gastro-intestinal central nervous system oncology urology and gynaecology as well as vitamins minerals and nutrients; and pain analgesic anti-diabetic and neurology products. It also provides pregnancy detection kits and condoms. The company was incorporated in 1973 and is headquartered in Mumbai India.
View LessPositive Momentum
Low 6-Month Volatility (<30%)
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Weakness based on declining price with high volume
Midcap (2B - 10B USD)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
25.4%1 month
27.6%3 months
29.1%6 months
23.2%35.71
33.11
6.98
0.14
0.09
25.69
5.53
-
24.36B
672.79B
7.17B
0.16
17.42
90.20
2.20
17.98
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
553.50
Range1M
660.00
Range3M
840.00
Rel. volume
1.63
Price X volume
1.12B
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Glenmark Pharmaceuticals Limited | GLENMARK | Drug Manufacturers-Specialty & Generic | 2240 | 632.10B | 0.31% | n/a | 15.68% |
| Laurus Labs Limited | LAURUSLABS | Drug Manufacturers-Specialty & Generic | 1096.1 | 590.97B | -1.64% | 172.16 | 62.70% |
| Biocon Limited | BIOCON | Biotechnology | 357.8 | 427.24B | -1.02% | 25.67 | 64.84% |
| Ipca Laboratories Limited | IPCALAB | Drug Manufacturers-Specialty & Generic | 1494.8 | 379.24B | 1.24% | 72.46 | 22.72% |
| Ajanta Pharma Limited | AJANTPHARM | Drug Manufacturers-Specialty & Generic | 2779.2 | 352.02B | -0.43% | 47.17 | 0.99% |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | Drug Manufacturers-Specialty & Generic | 1977.8 | 307.18B | -0.76% | 51.20 | 12.92% |
| Wockhardt Limited | WOCKPHARMA | Drug Manufacturers-Specialty & Generic | 1450.3 | 222.51B | 3.03% | n/a | 70.14% |
| Neuland Laboratories Limited | NEULANDLAB | Drug Manufacturers-Specialty & Generic | 15067 | 211.56B | 0.99% | 53.76 | 7.44% |
| AstraZeneca Pharma India Limited | ASTRAZEN | Drug Manufacturers-Specialty & Generic | 8440 | 211.00B | -0.14% | 197.18 | 0.65% |
| Piramal Pharma Limited | PPLPHARMA | Biotechnology | 153.81 | 203.34B | 1.99% | 805.68 | 59.54% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Hindustan Copper Limited | HINDCOPPER | Copper | 556.95 | 538.58B | 0.92% | 87.06 | 9.74% |
| AFFLE | AFFLE | Advertising Agencies | 1446.4 | 202.28B | -1.13% | 67.64 | 7.31% |
| Vedant Fashions Limited | MANYAVAR | Apparel Retail | 449.95 | 110.06B | -0.20% | 84.26 | 27.74% |
| Vertoz Advertising Limited | VERTOZ | Advertising Agencies | 51.24 | 44.95B | 1.41% | 48.67 | 10.74% |
| Signpost India Limited | SIGNPOST | Advertising Agencies | 277.25 | 16.25B | 1.98% | 30.54 | 80.30% |
| "SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 103.52 | 15.25B | 2.86% | 28.83 | 43.67% |
| V2 Retail Limited | V2RETAIL | Apparel Retail | 205.52 | 7.33B | 4.01% | 120.49 | 191.28% |
| Bhagyanagar India Ltd | BHAGYANGR | Copper | 210.57 | 6.80B | -1.93% | 36.36 | 52.08% |
| Madhav Copper Limited | MCL | Copper | 60.51 | 1.67B | -0.80% | 82.22 | 32.14% |
| Cubex Tubings Limited | CUBEXTUB | Copper | 93.83 | 1.36B | 0.75% | 35.85 | 21.78% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 25.69 | 24.85 | Par |
| Ent. to Revenue | 5.53 | 11.40 | Cheaper |
| PE Ratio | 35.71 | 51.36 | Cheaper |
| Price to Book | 6.98 | 6.83 | Par |
| Dividend Yield | 0.16 | 0.52 | Poor |
| Std. Deviation (3M) | 29.09 | 42.17 | Lower Risk |
| Debt to Equity | 0.14 | 0.35 | Cheaper |
| Debt to Assets | 0.09 | 0.17 | Cheaper |
| Market Cap | 672.79B | 290.82B | Market Leader |